Risk factors associated with subclinical atherosclerosis in the patients with biopsy-proven non-alcoholic fatty liver disease

被引：0

作者：

Arai, Taeang ^{[1
]}

Atsukawa, Masanori ^{[1
]}

Tsubota, Akihito ^{[2
]}

Yoshida, Yuji ^{[3
]}

Okubo, Tomomi ^{[3
]}

Hayama, Korenobu ^{[1
]}

Nakagawa, Ai ^{[1
]}

Itokawa, Norio ^{[3
]}

Kondo, Chisa ^{[1
]}

Iio, Etsuko ^{[4
]}

Tanaka, Yasuhito ^{[4
]}

Iwakiri, Katsuhiko ^{[1
]}

机构：

[1] Nippon Med Sch, Div Gastroenterol & Hepatol, Dept Internal Med, Bunkyo City, Japan

[2] Jikei Univ, Res Ctr Med Sci, Core Res Facil Basic Sci, Sch Med, Minato City, Japan

[3] Chiba Hokusoh Hosp, Div Gastroenterol, Dept Internal Med, Nippon Med Sch, Inzai, Japan

[4] Nagoya City Univ, Dept Virol & Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU056

引用

页码：S168 / S169

页数：2

共 50 条

[1] Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
Arai, Taeang
Atsukawa, Masanori
Tsubota, Akihito
Kawano, Tadamichi
Koeda, Mai
Yoshida, Yuji
Tanabe, Tomohide
Okubo, Tomomi
Hayama, Korenobu
Iwashita, Ai
Itokawa, Norio
Kondo, Chisa
Kaneko, Keiko
Kawamoto, Chiaki
Hatori, Tsutomu
Emoto, Naoya
Iio, Etsuko
Tanake, Yasuhito
Iwakiri, Katsuhiko
[J]. PLOS ONE, 2019, 14 (11):
[2] EXERCISE BEHAVIOR IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE
Glass, Oliver
Wang, Ying
Liu, Daniel
Guy, Cynthia D.
Diehl, Anna Mae
Abdelmalek, Manal F.
[J]. HEPATOLOGY, 2019, 70 : 748A - 748A
[3] FACTORS INFLUENCING SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE
Arai, Taeang
Atsukawa, Masanori
Tsubota, Akihito
Yoshida, Yuji
Okubo, Tomomi
Iwashita, Ai
Itokawa, Norio
Kondo, Chisa
Iio, Etsuko
Tanaka, Yasuhito
Iwakiri, Katsuhiko
[J]. HEPATOLOGY, 2019, 70 : 1364A - 1365A
[4] Incidence of Non-Alcoholic Fatty Liver Disease in Patients With Biopsy-Proven Celiac Disease
Shah, Apeksha
Wong, She-Yan
Janowski, Raymond
Moleski, Stephanie M.
Halegoua-De Marzio, Dina
[J]. GASTROENTEROLOGY, 2016, 150 (04) : S1145 - S1145
[5] Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration
Patel, Y. A.
Gifford, E. J.
Glass, L. M.
McNeil, R.
Turner, M. J.
Han, B.
Provenzale, D.
Choi, S. S.
Moylan, C. A.
Hunt, C. M.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 268 - 278
[6] Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones
Garcia-Monzon, Carmelo
Vargas-Castrillon, Javier
Luis Porrero, Jose
Teresa Alonso, Maria
Bonachia, Oscar
Jose Castillo, Maria
Marcos, Alberto
Quiros, Esther
Ramos, Beatriz
Sanchez-Cabezudo, Carlos
Villar, Sol
Saez, Alicia
Rodriguez de Cia, Javier
del Pozo, Elvira
Vega-Piris, Lorena
Soto-Fernandez, Susana
Lo Iacono, Oreste
Eugenia Miquilena-Colina, Maria
[J]. LIVER INTERNATIONAL, 2015, 35 (08) : 1983 - 1991
[7] Biopsy-proven Non-alcoholic Fatty Liver Disease and Incident Cancer
Kim, Hee Yeon
[J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (06): : 362 - 363
[8] FACTORS ASSOCIATED WITH LIVER TRANSPLANTATION IN TYPE-2 DIABETICS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE
Singh, Amandeep
Lan, Nan
Alsuleiman, Bayan
Alkhouri, Naim
Wakim-Fleming, Jamile
[J]. GASTROENTEROLOGY, 2019, 156 (06) : S1263 - S1263
[9] Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease
Celikbilek, Mehmet
Gursoy, Sebnem
Deniz, Kemal
Karaman, Ahmet
Zararsiz, Gokmen
Yurci, Alper
[J]. PLATELETS, 2013, 24 (03) : 194 - 199
[10] Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels
Ulasoglu, Celal
Enc, Feruze Yilmaz
Kaya, Eda
Yilmaz, Yusuf
[J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 427 - 431

← 1 2 3 4 5 →